Nexien BioPharma, Inc (OTC: NXEN) CEO Interview with Alex Wasyl discussing the company’s cannabinoid-based drug development pipeline. Drug development targets include, epliepsy, myotonia and other markets.
Hoth Therapeutics, Inc. (NASDAQ: HOTH) will be a featured presenter at Wall Street Reporter’s Next Super Stock Live! online investor conference on September 25, 2019. Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential! Thank […]
Nancy Bush Huber brings over 25 years of executive management roles, primarily as CFO of several publicly traded and private companies- Most recent position was as CFO of consumer packaged goods company for 13 years- […]
Company to Host Financial Results Conference Call and Update on Business Developments on Thursday, April 25, 2019, at 4:15 p.m. ET DENVER, April 17, 2019 — Medicine Man Technologies, Inc. (otcqx:MDCL) (“Medicine Man Technologies” or “Company”), […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
